Brief: Plus Therapeutics FY Net Income USD -13.316 Million
05/03/2024 21:05
Mar 05 (Reuters) - Plus Therapeutics FY operating expenses USD 18.234 million. * FY basic EPS USD -4.24 * FY operating income USD -13.321 million
Recent news on Cerenome
See all newsBrief: Cerenome Secures In-Network Agreement With Florida Blue For Cnside® Csf Tumor Cell Enumeration And Molecular Profile Tests
Plus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Cerenome Secures In-Network Agreement With Health Care Service Corporation
Plus Therapeutics Inc expected to post a loss of 91 cents a share - Earnings Preview
Brief: Plus Therapeutics Secures Regional Coverage Agreement With Medical Mutual For CNSide Cerebrospinal Fluid Assay For Metastatic CNS Cancer